Peritoneal Mesothelial Neoplasm — Trials

Peritoneal Mesothelial Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

27 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–7 of 7 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02399371	Pembrolizumab in Treating Patients With Malignant Mesothelioma	completed	Phase 2	65	University of ChicagoOTHER	1	May 8, 2026	clinicaltrials
NCT05449366	Intraperitoneal Paclitaxel for Patients With Primary Malignant Peritoneal Mesothelioma(INTERACT MESO)	completed	Phase 1 / Phase 2	7	Erasmus Medical CenterOTHER	1	Sep 2, 2025	clinicaltrials
NCT02040142	HIPEC for Peritoneal Carcinomatosis	completed	Phase 2	51	Albert Einstein College of MedicineOTHER	1	Oct 24, 2024	clinicaltrials
NCT05041062	A Study of Immunotherapy Drugs Nivolumab and Ipilimumab in Patients w/Resectable Malignant Peritoneal Mesothelioma

Data updated 22 days agoSource updated May 8, 2026source: clinicaltrials